The Canadian government signs an agreement with AstraZeneca to procure 100,000 doses of the Evushield COVID-19 antibody therapy for use in high-risk patients.
The Canadian government signs an agreement with AstraZeneca to procure 100,000 doses of a COVID-19 antibody therapy Evushield for high-risk patients.
The Canadian government signs an agreement with AstraZeneca to procure 100,000 doses of theEvushieldCOVID-19 antibody therapy foruse in high-risk patients.